rs786205841

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_003098.3(SNTA1):​c.128G>A​(p.Ser43Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000453 in 1,380,402 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00020 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00048 ( 1 hom. )

Consequence

SNTA1
NM_003098.3 missense

Scores

1
2
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:1

Conservation

PhyloP100: 1.05
Variant links:
Genes affected
SNTA1 (HGNC:11167): (syntrophin alpha 1) Syntrophins are cytoplasmic peripheral membrane scaffold proteins that are components of the dystrophin-associated protein complex. This gene is a member of the syntrophin gene family and encodes the most common syntrophin isoform found in cardiac tissues. The N-terminal PDZ domain of this syntrophin protein interacts with the C-terminus of the pore-forming alpha subunit (SCN5A) of the cardiac sodium channel Nav1.5. This protein also associates cardiac sodium channels with the nitric oxide synthase-PMCA4b (plasma membrane Ca-ATPase subtype 4b) complex in cardiomyocytes. This gene is a susceptibility locus for Long-QT syndrome (LQT) - an inherited disorder associated with sudden cardiac death from arrhythmia - and sudden infant death syndrome (SIDS). This protein also associates with dystrophin and dystrophin-related proteins at the neuromuscular junction and alters intracellular calcium ion levels in muscle tissue. [provided by RefSeq, Jan 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.059790134).
BS2
High AC in GnomAd4 at 31 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SNTA1NM_003098.3 linkuse as main transcriptc.128G>A p.Ser43Asn missense_variant 1/8 ENST00000217381.3 NP_003089.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SNTA1ENST00000217381.3 linkuse as main transcriptc.128G>A p.Ser43Asn missense_variant 1/81 NM_003098.3 ENSP00000217381 P1Q13424-1

Frequencies

GnomAD3 genomes
AF:
0.000205
AC:
31
AN:
151322
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000967
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000132
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000369
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000138
AC:
10
AN:
72496
Hom.:
0
AF XY:
0.0000714
AC XY:
3
AN XY:
42022
show subpopulations
Gnomad AFR exome
AF:
0.00115
Gnomad AMR exome
AF:
0.0000733
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000300
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000484
AC:
595
AN:
1228972
Hom.:
1
Cov.:
31
AF XY:
0.000447
AC XY:
270
AN XY:
603624
show subpopulations
Gnomad4 AFR exome
AF:
0.0000394
Gnomad4 AMR exome
AF:
0.0000431
Gnomad4 ASJ exome
AF:
0.0000490
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000349
Gnomad4 NFE exome
AF:
0.000573
Gnomad4 OTH exome
AF:
0.000407
GnomAD4 genome
AF:
0.000205
AC:
31
AN:
151430
Hom.:
0
Cov.:
31
AF XY:
0.000189
AC XY:
14
AN XY:
74002
show subpopulations
Gnomad4 AFR
AF:
0.0000965
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000369
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000142
Hom.:
0
Bravo
AF:
0.000208

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Long QT syndrome 12 Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsMay 12, 2022- -
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGeneDxJul 15, 2024Identified in a patient with arrhythmia in the published literature; however, this patient also harbored an additional cardiogenetic variant (PMID: 30847666); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 30847666) -
Congenital long QT syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Long QT syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpApr 28, 2023In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SNTA1 protein function. ClinVar contains an entry for this variant (Variation ID: 190903). This missense change has been observed in individual(s) with arrhythmia (PMID: 30847666). This variant is present in population databases (rs786205841, gnomAD 0.03%). This sequence change replaces serine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 43 of the SNTA1 protein (p.Ser43Asn). -
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsNov 02, 2022This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.69
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.31
T
Eigen
Benign
-0.19
Eigen_PC
Benign
-0.084
FATHMM_MKL
Benign
0.27
N
LIST_S2
Benign
0.64
T
M_CAP
Uncertain
0.27
D
MetaRNN
Benign
0.060
T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
1.3
L
MutationTaster
Benign
0.79
D
PrimateAI
Pathogenic
0.95
D
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.12
Sift
Benign
0.15
T
Sift4G
Benign
0.18
T
Polyphen
0.0030
B
Vest4
0.053
MutPred
0.20
Gain of catalytic residue at S43 (P = 0.0051);
MVP
0.32
MPC
0.26
ClinPred
0.026
T
GERP RS
3.5
Varity_R
0.19
gMVP
0.32

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs786205841; hg19: chr20-32031299; API